Author

Svetlana Romanova

Observed names: S. Romanova, S. Yu. Romanova, S.Y. Romanova, S.Yu. Romanova

Institution: Centre for Prevention and Control of AIDS and Infectious Diseases

Observed institutions: Centre for Prevention and Control of AIDS and Infectious Diseases, Ministry of Health of the Russian Federation

ORCID: 0000-0002-7479-1023

Observed ORCID: 0000-0002-7479-1023

OpenAlex ID: A5034191125

Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2b trial

2023 · Man-Fung Yuen, Tarik Asselah, et al. · The Lancet. Gastroenterology & hepatology · 106

Safety and Efficacy of Pegylated Interferon Lambda, Ribavirin, and Daclatasvir in HCV and HIV-Coinfected Patients

2017 · Mark Nelson, Rafael Rubio, et al. · Journal of Interferon & Cytokine Research · 19

Sofosbuvir/velpatasvir for the treatment of HCV: excellent results from a phase-3, open-label study in Russia and Sweden

2018 · Vasily Isakov, Vladimir Chulanov, et al. · Scandinavian Journal of Infectious Diseases · 14

Treatment of the chronic hepatitis C complicated by mixed cryoglobulinemia with direct-acting antiviral agents

2018 · N. V. Dunaeva, E. Yu. Kolpashchikova, et al. · Journal Infectology · 3

Real-world effectiveness and safety of pan-genotypic antiviral therapy for chronic HCV-infection: data from three clinical centers in St. Petersburg

2023 · D. A. Gusev, K. V. Zhdanov, et al. · Journal Infectology · 2

Efficacy and safety of bulevirtide in chronic hepatitis D – real life experience in Saint Petersburg

2023 · K.V. Zhdanov, D.А. Gusev, et al. · Infekcionnye bolezni · 1

Eradication of hepatitits C virus in patient with cryoglobulinemic vasculitis and mutations D168E, L31V

2020 · N. V. Dunaeva, M. A. Chirskaya, et al. · Journal Infectology · 1

Cepeginterferon alfa-2b in combination with ribavirin for treatment of chronic hepatitis C in patients co-infected with HIV-1 (final results of a multicenter randomized study)

2016 · F. Nagimova, V. Rassokhin, et al. · Infekcionnye bolezni · 1

Antiviral therapy for chronic hepatitis D – real-world experience in Saint Petersburg

2026 · D.A. Gusev, D.A. Gusev, et al. · Infekcionnye bolezni

Socio-Epidemiological and Clinical-Laboratory Characteristics of Patients with HIV and Chronic Hepatitis B+D

2025 · E. B. Yastrebova, A. G. Trishina, et al. · Journal Infectology

The case of coinfection with human immunodeﬁciency and hepatitis С viruses during hemotransfusion: clinical and socio-legal consequences

2024 · M. A. Bulygin, V. D. Shamigulov, et al. · HIV Infection and Immunosuppressive Disorders

Incidence, risk factors, and severity of clinical manifestations of skin vasculitis in patients with HCV- and HCV/HIV-infection

2023 · N. V. Dunaeva, S. Yu. Romanova, et al. · Сибирский журнал клинической и экспериментальной медицины

Analysis of mortality and risk of death in HCV- and HCV/HIV-infected patients with extrahepatic manifestations

2022 · N. V. Dunaeva, Yu. I. Ulitina, et al. · Journal Infectology

SAT-174-Formation of the occult chronic hepatitis B during antiviral therapy in patients with HIV + HBV + HDV + HCV infection: Clinical cases

2019 · Konstantin Zhdanov, Ilnur Gabdrakhmanov, et al. · Journal of Hepatology

Inflammatory myopathy with autoantibodies to signalrecognition particles in a patient with chronic hepatitis C

2018 · N.V. Dunaeva, M.A. Gezey, et al. · Infekcionnye bolezni

Works count: 15

Citation count: 147

H-index: 3

I10-index: 3